Company / Current Assets per Share
Inhibrx Biosciences, Inc. Current Assets per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$9.18
FY2025
5-year range
$3.39 / $25.07
FY2023-FY2025
Trend
+171.0%
vs FY2024
Sector context
#81 of 210
Health Care
What the data says
At $9.18, Inhibrx Biosciences, Inc.'s current assets per share ranks #81 of 210 in the Health Care sector. Declined from $25.07 to $9.18 over the past 2 years.
Based on SEC 10-K filings.
9.18 in FY2025.
Declined from $25.07 to $9.18 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 210 in Health CareTop 39% of 210This company $9.18 Sector average $170.65
▼
-94.6% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 171.0% year-over-year.
- Ranks #81 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.18 | +171.0% |
| FY2024 | $3.39 | -86.5% |
| FY2023 | $25.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026